B of A Securities Maintains Buy on Vertex Pharmaceuticals, Raises Price Target to $295

B of A Securities maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Buy and raises the price target from $250 to $295.

Benzinga · 01/31/2020 16:44

B of A Securities maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Buy and raises the price target from $250 to $295.